One in eight ladies will get breast cancer. A new imaging system for the breast have
been located. The professionals at HICCC found it and they are excelling. The Diffuse
Optical Tomography (DOT) utilizes a family of light waves that does investigate the mo-
difications within the breast tissue.
The waves of light shows them photos of the actions inside the breast. They are able
to view the difference between regular tissue and irregular tissue. The system does n-
ot cost a lot but it is still a top-quality one for searching for breast cancer.
It has no breast compression or ionized radiation like mammograms. It contains no in-
travenous contrast dyes like MRI's. The breast cancer patients are not confined in tight
spaces. The Diffuse Optical Tomography machine's wattage is similar to ones that are
in light bulbs. The process does not invade at all.
The breast cancer patients get their examinations done between 15 & 20 minutes. The
Diffuse Optical Tomography is a great tool that divulges information to the professionals
quickly, so they get better ideas for therapies. The results let them know if chemothera-
py will be beneficial to the ladies.
The breast images are done just a few weeks after chemotherapy and they receive pert-
inent info from the results. The lively imaging markers can tell which newly diagnosed br-
east cancer patients will reply greatly to chemotherapy, before surgeries. That could rev-
olutionize and better the management of breast cancer in time.
The HICCC partnered with the Columbia biomedical engineers. They included patients in
a research study utilizing the Diffuse Optical Tomography, so the researchers implement-
ed a baseline measurement of the cancer cells in breast.
They did a comparison of those measurements with ones that were used at six separate
periods of time, which included 2 weeks later and before surgery. The study conductors
realized that DOT done early let them know which ladies will reply highly to therapies be-
fore surgeries.
They expanded to analyze the various types of breast cancer. A second research study h-
as been planned for this year. It will aim for the ways that breast cancer patients reply to a-
nti-angiogenesis drugs.
Those drugs are known to help plenty of patients. We need to applaud them for the extens-
ive tests that they are doing. Ladies are so precious and we forever need them live to get w-
ell.
No comments:
Post a Comment